Location: Home
  • search
  • go
  • Relate News
  • 12/10/2024The Proposed BIOSECURE Act Faces Setback in Senate
  • 12/10/2024Hong Kong Takes Key Step Towards Becoming a Medical Hub with New Clini...
  • 12/10/2024Oxford Nanopore Sues Chinese Biotech Giant BGI Over Alleged Misuse of ...
  • 12/10/2024NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-...
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024Huadong and Kiniksa's Rilonacept Gains Approval in China for Recurrent...
  • 12/10/2024Eisai's Dotinurad Approved in China for Gout
  • 12/10/2024China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
  • 12/10/2024Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
  • 12/10/2024CU Medicine Partners with CTTQ to Propel Pharma Innovations in Hong Ko...
  • 12/10/2024China and India to Lead Health Spending Growth in 2025 amid Emerging M...
  • 12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)
  • 12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • 12/9/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (89...
  • 12/9/2024Nicox Launches Zerviate in China thru OcuMension Therapeutics
  • 12/9/2024CStone Unveils Promising Clinical Data on CS5001 for Advanced Lymphoma...
  • 12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
  • 12/9/2024Hengrui Medicine to Issue H-Shares and Pursue Hong Kong Main Board Lis...
  • 12/9/2024Domestic Pharma Cos Poised to Gain in Chinese GLP-1 Obesity Drug Marke...
  • 12/8/2024BioNTech and DualityBio Unveil Promising Interim Results for Partnered...
  • 12/8/2024ChipScreen Announces Mixed Phase III Results for Chiauranib in SCLC Tr...
  • 12/6/2024Implications of China's Growing Influence in Global Pharma / API Suppl...
  • 12/6/2024China's Expanding Proton Therapy Market: Key Drivers
  • 12/6/2024Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
  • 12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15
  • Page:46/786 Total number of articles:23558: [First][<<] [44] [45] [46] [47] [48] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group